Prima BioMed Ltd to Ring The NASDAQ Stock Market Opening Bell to Celebrate Listing on The NASDAQ Stock Market

ADVISORY, April 16, 2012 (GLOBE NEWSWIRE) --

What:

Prima BioMed Ltd, a world leader in cancer immunotherapies, will visit the NASDAQ MarketSite in Times Square to celebrate its listing on The NASDAQ Stock Market. Prima BioMed Ltd. begins trading on NASDAQ today, April 16, 2012.

Prima's listing on NASDAQ comes at a significant point in the development timeline for CVac™ ovarian cancer vaccine. The timing should offer U.S, investors an opportunity to share in this growth phase of the Company.

In honor of the occasion, Martin Rogers, CEO will ring the Opening Bell.

Where:

NASDAQ MarketSite — 4 Times Square — 43^rd & Broadway — Broadcast Studio

When:

Monday, April 16, 2012 — 9:15 a.m. to 9:30 a.m. ET

Contact:

Ian Bangs
+61 9276 1250
Ian.bangs@primabiomed.com.au

NASDAQ MarketSite:

Jen Knapp
(212) 401-8916
Jennifer.knapp@nasdaqomx.com

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Facebook and Twitter:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
http://www.facebook.com/#!/NASDAQ.        

For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaqomx

Webcast:

A live webcast of the NASDAQ Opening Bell will be available at:
http://www.nasdaq.com/about/marketsitetowervideo.asx.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Prima BioMed Ltd:

Prima BioMed is an ASX and NASDAQ listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.

Prima's lead product is the CVac^TM ovarian cancer therapy treatment. It has completed two successful clinical trials and is progressing toward eventual commercialisation in the United States, Australia, Europe, and globally.

The Company's broader, long term goal is to develop commercial cancer treatment technologies and programs for global markets.

About NASDAQ OMX:

The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the US and Europe, we own and operate 24 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to traffic more than 1 million messages per second at sub-40 microsecond speeds with 99.999% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $5.1 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily.  Welcome to the NASDAQ OMX Century.  To learn more, visit www.nasdaqomx.com. Follow us on Facebook ( http://www.facebook.com/NASDAQ) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500).

-NDAQA-

News Provided by Acquire Media